Pilot Study on the Use of iENTER, iCONSENT and iPARTICIPATE E-tools

NCT06317961 | Recruiting

• 1 other identifier: INT200-22
• Study Type: observational
• Target: 30
• Locations: 1 country
• Sites: 1

Brief Summary

Precision oncology is the future of fighting cancer. Cancer Core Europe (CCE) developed a precision medicine trial, i.e. the Basket of Basket (BoB) study, to provide personalised treatment to a large number of patients by incorporating a molecular profiling platform. The EU-funded CCE\_DART project, developed within the CCE Consortium, is aimed at improving efficiency and transform platform trials into data-rich translational research programmes. Within the CCE\_DART project working area D "Patient involvement through information and partnership" three interconnected web e-tools were developed aimed at promoting patient information, recruitment, and involvement as well as facilitating adherence to the CCE BoB trial: 1) iENTER: informative web site addressed to potential BoB trial participants, their caregivers, patients' advocates, and the public; 2) iCONSENT: web app for remote management of the informed consent process in the CCE BoB trial.3) iPARTICIPATE: web app allowing remote access to BoB trial patients trial visits calendar, medications list and posology, to upload documents and download reports, messaging between patients and clinical staff. The main objective of this study is to carry out field testing and assess usability of the e-tools iENTER, iCONSENT and iPARTICIPATE. The study is also addressed at collecting patients' suggestions for improvements of the e-tools.

Conditions

Cancer

Outcome Measures

Primary Outcomes (1)

• SUS questionnaire

  The SUS questionnaire consists of 10 Likert type items with five response options (from Strongly agree to Strongly disagree).

  31-1-2025

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients enrolled in the CCE BoB trial

You may qualify if:

• Cancer patients, or their informal caregivers, candidates to precision oncology trials. Patients or caregivers able to surf the internet and to fill in a simple online form.

You may not qualify if:

• People with clinically evident cognitive impairment.

Sponsors & Collaborators

• Fondazione IRCCS Istituto Nazionale dei Tumori, Milano: lead
• Vall d'Hebron Institute of Oncology: collaborator
• The Netherlands Cancer Institute: collaborator

Study Sites (1)

Fondazione IRCCS Istituto Nazionale dei Tumori

Milan, 20133, Italy

RECRUITING

Related Links

• This website provides information that may be helpful in the process of decision making about clinical trial participation. It is targeted to patients and/or their caregivers, but it can also be used by the general public.
• Building Data Rich Clinical Trials CCE\_DART is an innovative EU-funded project dedicated to deliver novel methods for the design and implementation of newer, more efficient and effective clinical trials in oncology

MeSH Terms

Conditions

Neoplasms

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: March 12, 2024
• First Posted: March 19, 2024
• Study Start: April 5, 2023
• Primary Completion: January 31, 2025
• Study Completion: January 31, 2025
• Last Updated: March 19, 2024

Record last verified: 2024-03

Data Sharing

• IPD Sharing: Will not share

Locations

IT (1)